Talitrace

Talitrace is a preclinical-stage liposomal nanoparticle diagnostic agent developed by InnoMedica for the intraoperative identification of solid tumors. It utilizes InnoMedica's proprietary liposomal nanocarrier platform, which is designed to selectively accumulate in tumor tissues, likely through the enhanced permeability and retention (EPR) effect. By localizing specifically within solid tumors, Talitrace enables real-time visualization and identification of malignant tissue during surgical procedures. This technology aims to assist surgeons in achieving more precise tumor resections by clearly distinguishing cancerous margins from surrounding healthy tissue.